BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. [DOI: 10.1007/s13238-020-00799-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Wen G, Li M, Li F, Yang Z, Zhou T, Gu W. AQUARIUM: accurate quantification of circular isoforms using model-based strategy. Bioinformatics 2021:btab435. [PMID: 34115093 DOI: 10.1093/bioinformatics/btab435] [Reference Citation Analysis]
2 Yu W, Gu Q, Wu D, Zhang W, Li G, Lin L, Lowe JM, Hu S, Li TW, Zhou Z, Miao MZ, Gong Y, Zhao Y, Lu E. Identification of potentially functional circRNAs and prediction of circRNA-miRNA-mRNA regulatory network in periodontitis: Bridging the gap between bioinformatics and clinical needs. J Periodontal Res 2022. [PMID: 35388494 DOI: 10.1111/jre.12989] [Reference Citation Analysis]
3 Jiang T, Wang H, Liu L, Song H, Zhang Y, Wang J, Liu L, Xu T, Fan R, Xu Y, Wang S, Shi L, Zheng L, Wang R, Song J. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Mol Cancer 2021;20:167. [PMID: 34922544 DOI: 10.1186/s12943-021-01474-9] [Reference Citation Analysis]
4 Zhang Y, Zhao Y, Cole T, Zheng J, Bayinqiaoge, Guo J, Tang SY. Microfluidic flow cytometry for blood-based biomarker analysis. Analyst 2022;147:2895-917. [PMID: 35611964 DOI: 10.1039/d2an00283c] [Reference Citation Analysis]
5 Nie G, Peng D, Li B, Lu J, Xiong X. Diagnostic Accuracy of Circular RNAs in Different Types of Samples for Detecting Hepatocellular Carcinoma: A Meta-Analysis. Front Genet 2021;12:794105. [PMID: 34992634 DOI: 10.3389/fgene.2021.794105] [Reference Citation Analysis]
6 De Palma FDE, Salvatore F, Pol JG, Kroemer G, Maiuri MC. Circular RNAs as Potential Biomarkers in Breast Cancer. Biomedicines 2022;10:725. [PMID: 35327527 DOI: 10.3390/biomedicines10030725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Tong KL, Tan KE, Lim YY, Tien XY, Wong PF. CircRNA-miRNA interactions in atherogenesis. Mol Cell Biochem 2022. [PMID: 35604519 DOI: 10.1007/s11010-022-04455-8] [Reference Citation Analysis]
8 Lv C, Sun W, Huang J, Qin Y, Ji X, Zhang H. Expression Profiles of Circular RNAs in Human Papillary Thyroid Carcinoma Based on RNA Deep Sequencing. Onco Targets Ther 2021;14:3821-32. [PMID: 34188490 DOI: 10.2147/OTT.S316292] [Reference Citation Analysis]
9 Xu T, He B, Sun H, Xiong M, Nie J, Wang S, Pan Y. Novel insights into the interaction between N6-methyladenosine modification and circular RNA. Mol Ther Nucleic Acids 2022;27:824-37. [PMID: 35141044 DOI: 10.1016/j.omtn.2022.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lu H, Yang Y, Kuang D, Liu P, Yang J. Expression profile of circRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis. BMC Med Genomics 2022;15:77. [PMID: 35379246 DOI: 10.1186/s12920-022-01225-9] [Reference Citation Analysis]
11 Zhu L, Wang Z, Sun L, Zheng D, Hu B, Li N, Shao G. Hsa_circ_0000437 upregulates and promotes disease progression in rheumatic valvular heart disease. J Clin Lab Anal 2021;:e24197. [PMID: 34952991 DOI: 10.1002/jcla.24197] [Reference Citation Analysis]
12 Ouyang Q, Liu C, Lu X, Liang R, Zhao J, Yang M. Identification of Circular RNAs Circ_0005008 and Circ_0005198 in Plasma as Novel Biomarkers for New-Onset Rheumatoid Arthritis. Front Pharmacol 2021;12:722017. [PMID: 34539405 DOI: 10.3389/fphar.2021.722017] [Reference Citation Analysis]
13 Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacol Ther 2022;234:108123. [PMID: 35121000 DOI: 10.1016/j.pharmthera.2022.108123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shu J, Su G, Zhang J, Liu Z, Chang R, Wang Q, Yang P. Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease. Front Immunol 2021;12:738760. [PMID: 35003060 DOI: 10.3389/fimmu.2021.738760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 D'Ambrosi S, Visser A, Antunes-Ferreira M, Poutsma A, Giannoukakos S, Sol N, Sabrkhany S, Bahce I, Kuijpers MJE, Oude Egbrink MGA, Griffioen AW, Best MG, Koppers-Lalic D, Oudejans C, Würdinger T. The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:4644. [PMID: 34572871 DOI: 10.3390/cancers13184644] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Luo H, Peng J, Yuan Y. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5. Cell Cycle 2022. [PMID: 35482822 DOI: 10.1080/15384101.2022.2071565] [Reference Citation Analysis]
17 Li S, Hu W, Deng F, Chen S, Zhu P, Wang M, Chen X, Wang Y, Hu X, Zhao B, Zhong W, Ma G, Li Y. Identification of Circular RNA hsa_circ_0001599 as a Novel Biomarker for Large-Artery Atherosclerotic Stroke. DNA Cell Biol 2021;40:457-68. [PMID: 33493415 DOI: 10.1089/dna.2020.5662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li P, Chen J, Zou J, Zhu W, Zang Y, Li H. Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 via the sponge effect on miR-129-5p. Bioengineered 2022;13:7181-96. [PMID: 35264065 DOI: 10.1080/21655979.2022.2036304] [Reference Citation Analysis]
19 Fang N, Ding GW, Ding H, Li J, Liu C, Lv L, Shi YJ. Research Progress of Circular RNA in Gastrointestinal Tumors. Front Oncol 2021;11:665246. [PMID: 33937077 DOI: 10.3389/fonc.2021.665246] [Reference Citation Analysis]
20 Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression. Signal Transduct Target Ther 2021;6:400. [PMID: 34815385 DOI: 10.1038/s41392-021-00788-w] [Reference Citation Analysis]
21 Guo M, Sun Y, Ding J, Li Y, Yang S, Zhao Y, Jin X, Li SS. Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma. Mol Med Rep 2021;24:603. [PMID: 34165176 DOI: 10.3892/mmr.2021.12241] [Reference Citation Analysis]
22 Chao F, Wang S, Zhang C, Han D, Xu G, Chen G. The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review. Front Cell Dev Biol 2021;9:681163. [PMID: 34386491 DOI: 10.3389/fcell.2021.681163] [Reference Citation Analysis]
23 He L, Man C, Xiang S, Yao L, Wang X, Fan Y. Circular RNAs' cap-independent translation protein and its roles in carcinomas. Mol Cancer 2021;20:119. [PMID: 34526007 DOI: 10.1186/s12943-021-01417-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Peter MR, Zhao F, Jeyapala R, Kamdar S, Xu W, Hawkins C, Evans AJ, Fleshner NE, Finelli A, Bapat B. Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma. Front Oncol 2022;11:814228. [DOI: 10.3389/fonc.2021.814228] [Reference Citation Analysis]
25 Xiao Q, Hou R, Li H, Zhang S, Zhang F, Zhu X, Pan X. Circulating Exosomal circRNAs Contribute to Potential Diagnostic Value of Large Artery Atherosclerotic Stroke. Front Immunol 2021;12:830018. [PMID: 35095932 DOI: 10.3389/fimmu.2021.830018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Varì R, Scazzocchio B, Filardi T, Citarella A, Bellenghi M, Masella R, Santangelo C. Significance of Sex Differences in ncRNAs Expression and Function in Pregnancy and Related Complications. Biomedicines 2021;9:1509. [PMID: 34829737 DOI: 10.3390/biomedicines9111509] [Reference Citation Analysis]
27 Zhang D, Ji Y, Chen X, Chen R, Wei Y, Peng Q, Lin J, Yin J, Li H, Cui L, Lin Z, Cai Y. Peripheral Blood Circular RNAs as a Biomarker for Major Depressive Disorder and Prediction of Possible Pathways. Front Neurosci 2022;16:844422. [DOI: 10.3389/fnins.2022.844422] [Reference Citation Analysis]
28 Ji C, Wang Y, Wei X, Zhang X, Cong R, Yao L, Qin C, Song N. Potential of testis-derived circular RNAs in seminal plasma to predict the outcome of microdissection testicular sperm extraction in patients with idiopathic non-obstructive azoospermia. Hum Reprod 2021;36:2649-60. [PMID: 34477868 DOI: 10.1093/humrep/deab196] [Reference Citation Analysis]
29 Omid-Shafaat R, Moayeri H, Rahimi K, Menbari MN, Vahabzadeh Z, Hakhamaneshi MS, Nouri B, Ghaderi B, Abdi M. Serum Circ-FAF1/Circ-ELP3: A novel potential biomarker for breast cancer diagnosis. J Clin Lab Anal 2021;35:e24008. [PMID: 34545638 DOI: 10.1002/jcla.24008] [Reference Citation Analysis]
30 Zhang Z, Qian H, Tao Z, Xie Y, Zhi S, Sheng L, He W, Zhang L. Circulating circular RNAs as biomarkers for the diagnosis of essential hypertension with carotid plaque. Clin Exp Hypertens 2022;:1-9. [PMID: 35787223 DOI: 10.1080/10641963.2022.2093894] [Reference Citation Analysis]
31 Li S, Liu F, Zheng K, Wang W, Qiu E, Pei Y, Wang S, Zhang J, Zhang X. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Mol Cancer 2021;20:161. [PMID: 34876132 DOI: 10.1186/s12943-021-01453-0] [Reference Citation Analysis]
32 Shen H, Liu B, Xu J, Zhang B, Wang Y, Shi L, Cai X. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol 2021;14:134. [PMID: 34461958 DOI: 10.1186/s13045-021-01145-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 He H, Zhang J, Gong W, Liu M, Liu H, Li X, Wu Y, Lu Q. Involvement of CircRNA Expression Profile in Diabetic Retinopathy and Its Potential Diagnostic Value. Front Genet 2022;13:833573. [DOI: 10.3389/fgene.2022.833573] [Reference Citation Analysis]
34 Guo X, Piao H. Research Progress of circRNAs in Glioblastoma. Front Cell Dev Biol 2021;9:791892. [PMID: 34881248 DOI: 10.3389/fcell.2021.791892] [Reference Citation Analysis]
35 Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S. CircRNAs and their regulatory roles in cancers. Mol Med 2021;27:94. [PMID: 34445958 DOI: 10.1186/s10020-021-00359-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Yang G, Song T, Wang M, Li M, Su Q, Xie Z, Xie X, Zhang H, Feng Y, Wu C, Liu Y, Yang H. Recent Advancements in Nanosystem-Based Molecular Beacons for RNA Detection and Imaging. ACS Appl Nano Mater 2022;5:3065-86. [DOI: 10.1021/acsanm.1c03966] [Reference Citation Analysis]
37 Lin H, Yu J, Gu X, Ge S, Fan X. Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology. Clin Transl Med 2021;11:e636. [PMID: 34898043 DOI: 10.1002/ctm2.636] [Reference Citation Analysis]
38 Li Y, Li R, Cheng D, Fu X, Fu L, Peng S. The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma. PeerJ 2022;10:e13640. [DOI: 10.7717/peerj.13640] [Reference Citation Analysis]
39 Scoditti E, Naccarati A, Carpi S, Polini B, Ebada SS, Nieri P. Editorial: Non-Coding RNAs as Mediators of the Activity of Natural Compounds. Front Pharmacol 2021;12:751956. [PMID: 34489715 DOI: 10.3389/fphar.2021.751956] [Reference Citation Analysis]